The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells
Hussin A. Rothan, Shannon Stone, Janhavi P. Natekar, Pratima Kumari, Komal Arora, Mukesh Kumar
Topics & Concepts
AuranofinDrugBiologyInflammationPharmacologyViral replicationDrug developmentCoronavirusDrug repositioningAntiviral drugVirologyImmunologyCoronavirus disease 2019 (COVID-19)DiseaseMedicineVirusInternal medicineInfectious disease (medical specialty)Rheumatoid arthritisSARS-CoV-2 and COVID-19 ResearchSirtuins and Resveratrol in MedicineMosquito-borne diseases and control